|
Market Closed -
Boerse Muenchen
16:43:09 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 0.4500 EUR | 0.00% |
|
+24.31% | +51.26% |
| 09-11 | Chinese Regulator Accepts Nicox's Glaucoma Drug Application for Review | MT |
| 09-11 | Nicox S.A. Announces Acceptance Of NCX 470 NDA For Review In China | CI |
Company Valuation: Nicox SA
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 109.8 | 55.83 | 22.05 | 19.32 | 24.12 | 30.32 | - |
| Change | - | -49.18% | -60.51% | -12.36% | 24.81% | 25.71% | - |
| Enterprise Value (EV) | 89.38 | 53.61 | 31.68 | 19.32 | 24.12 | 30.32 | 30.32 |
| Change | - | -40.02% | -40.9% | -39.01% | 24.81% | 25.71% | 0% |
| P/E | -2.18x | -1.78x | -1.05x | -0.88x | -9.93x | -6.88x | 17.2x |
| PBR | 1.45x | 1.04x | - | - | - | - | - |
| PEG | - | 0x | 0x | 0x | 0.1x | -0.1x | -0x |
| Capitalization / Revenue | 15.2x | 17.1x | 5.25x | 2.46x | 1.44x | 10.1x | 3.03x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 10.1x | 3.03x |
| EV / EBITDA | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | 0x | -6.06x | 15.2x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -1.17 | -0.63 | -0.42 | -0.32 | -0.03 | -0.05 | 0.02 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 7.233 | 3.271 | 4.2 | 7.859 | 16.77 | 3 | 10 |
| EBITDA | -16.61 | -22.86 | -17.04 | - | - | - | - |
| EBIT 1 | -46.01 | -33.96 | -17.06 | -9.854 | 4.626 | -5 | 2 |
| Net income 1 | -43.76 | -27.76 | -20.88 | -22.39 | -2.413 | -5 | 2 |
| Net Debt | -20.46 | -2.216 | 9.636 | - | - | - | - |
| Reference price 2 | 2.5550 | 1.1200 | 0.4420 | 0.2810 | 0.2980 | 0.3440 | 0.3440 |
| Nbr of stocks (in thousands) | 42,991 | 49,845 | 49,882 | 68,764 | 80,926 | 88,131 | - |
| Announcement Date | 4/28/22 | 3/20/23 | 4/22/24 | 4/29/25 | 4/30/26 | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 104.71x | 5.85x | 24.83x | 2.37% | 355B | |
| 22.26x | 3.02x | 10.56x | 1.79% | 66.33B | |
| 14.88x | 7.29x | 11.17x | - | 12.17B | |
| 13.99x | 1.73x | 5.87x | 3.17% | 7.47B | |
| 18.85x | 5.86x | 15.6x | -.--% | 4.64B | |
| 39.8x | 2.5x | 29.1x | 0.72% | 4.42B | |
| 32.78x | 5.15x | 15.09x | - | 2.86B | |
| -208.2x | - | - | -.--% | 2.42B | |
| Average | 4.88x | 4.49x | 16.03x | 1.34% | 56.93B | |
| Weighted average by Cap. | 85.19x | 5.37x | 21.95x | 2.24% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALCOX Stock
- NXOA Stock
- Valuation Nicox SA
Select your edition
All financial news and data tailored to specific country editions
